Correction to "A Double-Blind, Placebo-Controlled Trial of Rosiglitazone for Clozapine-Induced Glucose Metabolism Impairment in Patients with Schizophrenia"
- PMID: 41184203
- DOI: 10.1111/acps.70044
Correction to "A Double-Blind, Placebo-Controlled Trial of Rosiglitazone for Clozapine-Induced Glucose Metabolism Impairment in Patients with Schizophrenia"
Erratum for
-
A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophrenia.Acta Psychiatr Scand. 2009 Jun;119(6):457-65. doi: 10.1111/j.1600-0447.2008.01325.x. Epub 2009 Jan 12. Acta Psychiatr Scand. 2009. PMID: 19183127 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
